Streetbeat News

Legal

BNBUSD

FTTUSD

SOLUSD

Caroline Ellison, associated with cryptocurrency exchange FTX and Alameda Research, testified at Sam Bankman-Fried's criminal trial, revealing his aspirations to become the U.S. president and controversial practices at Alameda and FTX. She detailed how higher value coins on Binance (CRYPTO: BNB) were withdrawn from FTX to be sold on the competitor's platform. Ellison also discussed FTT tokens and 'Sam coins', including Solana (CRYPTO: SOL), and Bankman-Fried's willingness to take extreme risks.

Portfolio Pulse from Murtuza Merchant

October 10, 2023 | 7:35 pm

VRNOF

A bill in New York seeks to make smoking marijuana near children illegal, with increased penalties for repeat violations. Three new cannabis retailers have been approved to operate in the state. In Alabama, a former lawmaker is urging the Alabama Medical Cannabis Commission to issue medical cannabis licenses. In California, the Department of Fish and Wildlife has seized over 98,000 illicit cannabis plants in the last three months, focusing on large, unlicensed cultivation sites. A new law in Alaska consolidates the regulation of intoxicating hemp products with existing marijuana industry regulators, increasing taxes and enforcing a minimum purchase age of 21.

Portfolio Pulse from Jelena Martinovic

October 10, 2023 | 7:24 pm

COCH

Envoy Medical has settled an outstanding lawsuit filed by certain former shareholders of Envoy Medical Corporation, which is now a wholly-owned subsidiary of Envoy Medical, Inc. This news has led to a decrease in the company's share price.

Portfolio Pulse from Benzinga Newsdesk

October 10, 2023 | 5:02 pm

BTCUSD

FTTUSD

Former Alameda Research CEO Caroline Ellison has been called to testify at the fraud trial of Sam Bankman-Fried. The details of the case and its implications for Alameda Research and related assets are not provided.

Portfolio Pulse from Benzinga Newsdesk

October 10, 2023 | 4:37 pm

NSTG

TXG

The European Unified Patent Court (UPC) has declined to issue a second preliminary injunction against NanoString Technologies (NSTG) based on European Patent 2 794 928 B1. However, previous injunctions against NanoString's CosMx products in Europe remain in effect. In the US, 10x Genomics (TXG) has filed suits against NanoString alleging patent infringement and is seeking over $30 million in damages. Trials are scheduled for November 2023 and September 2024.

Portfolio Pulse from Benzinga Newsdesk

October 10, 2023 | 4:08 pm

SEEL

Empery Asset Management has accused Seelos Therapeutics of misrepresenting clinical trial data. The asset management firm alleges that Seelos has been misleading investors about the progress and results of its clinical trials.

Portfolio Pulse from Bill Haddad

October 10, 2023 | 2:55 pm

OMEX

Odyssey Marine Exploration, Inc. has received a letter from the International Centre for Settlement of Investment Disputes (ICSID) stating that the tribunal is close to completing the drafting of the award and expects to issue it in Q1 2024. Any changes to the timing estimate will be duly notified to the claimant.

Portfolio Pulse from Benzinga Newsdesk

October 10, 2023 | 1:22 pm

GENI

SRAD

SportsCastr Inc., operating as PANDA Interactive, has filed two separate complaints for infringement on its interactive streaming technology patents against Sportradar Group AG (NASDAQ:SRAD) and Genius Sports Limited (NYSE:GENI). The complaints were filed in the US District Court for the Eastern District of Texas. PANDA Interactive's technology combines actionable betting odds with any live or on-demand broadcast, aiming to enhance the fan-viewing experience.

Portfolio Pulse from Benzinga Newsdesk

October 10, 2023 | 12:49 pm

XPEV

Chinese electric vehicle manufacturer XPeng Inc (NYSE:XPEV) has suspended its Vice President, Li Feng, pending an internal corruption investigation. The company reassured stakeholders that the issue does not impact the company's overall operations or production links. XPeng has been focusing on enhancing supply chain management throughout the current year. Some members of the supply chain team have also been subjected to investigations.

Portfolio Pulse from Shivani Kumaresan

October 10, 2023 | 12:37 pm

COCH

Envoy Medical, Inc. (NASDAQ:COCH) has settled a lawsuit filed by former shareholders of its subsidiary, Envoy Medical Corporation (EMC). The lawsuit challenged certain financing transactions between EMC and board member Glen Taylor. The settlement was reached in August 2023, with the plaintiffs selling their EMC stock to an affiliate of Mr. Taylor.

Portfolio Pulse from Benzinga Newsdesk

October 10, 2023 | 12:32 pm